Better molecules. Faster.
Our Technology
molab.ai provides a step-change in drug and compound discovery through in silico property predictions with unprecedented performance
Market-leading property predictions
Our next-level property predictions (esp. ADMET) substantially accelerate and streamline drug and compound discovery.
Unparalleled robustness to data scarcity
We unlock new AI use cases, through unprecedented performance in data-scarce settings, including in vivo predictions.
Fully interpretable results
We empower scientists to iterate faster by uncovering molecular root causes for the characteristics under investigation.
Vast array of applications
Our integrated solution benefits a comprehensive range of applications across drug discovery and chemistry, such as in vivo ADME, toxicity, physiochemical properties and even scents and flavors.
About us
We are a purpose-driven AI company that combines scientific excellence, impact orientation and entrepreneurial drive. We leverage our unique technology and hands-on approach to our help our clients unlock substantial value, fast.
Our Vision
Precision molecules
for the benefit of
patients, people and the planet.
Our Team
Dr. Thilo Bauer
Co-Founder
Dr. Simon Tatomir
Co-Founder
Nikita Makarov
Data Science Intern
Isabell Weigert
Strategy and Operations Intern
Dr. Sebastian Stolzenberg